Mark Aleynick
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
- Immune cells in cancer
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
- Co-authors
- Joshua Brody (5 shared papers)Judit Svensson‐Arvelund (4 shared papers)Christopher R. Flowers (1 shared paper)Aurélien Marabelle (1 shared paper)Miriam Mérad (3 shared papers)Linda Hammerich (3 shared papers)Brian D. Brown (4 shared papers)Ranjan Upadhyay (4 shared papers)
- Journals
- Clinical Cancer Research (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Nature Communications (1 paper)Cancer Discovery (1 paper)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Mark Aleynick
5 papers receiving 95 citations
Peers
Comparison fields: 5 of 25
- Immunology 73
- Oncology 52
- Biotechnology 7
- Genetics 17
- Hematology 5
Countries citing papers authored by Mark Aleynick
This map shows the geographic impact of Mark Aleynick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aleynick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aleynick more than expected).
Fields of papers citing papers by Mark Aleynick
This network shows the impact of papers produced by Mark Aleynick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aleynick. The network helps show where Mark Aleynick may publish in the future.
Co-authors
The 18 scholars most cited alongside Mark Aleynick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 41 | |
| 2 | 2022 | 38 | |
| 3 | 2019 | 13 | |
| 4 | 2023 | 3 | |
| 5 | 2018 | 1 |
About Mark Aleynick
Mark Aleynick is a scholar working on Oncology, Immunology, Genetics, Infectious Diseases and Organic Chemistry, having authored 5 papers that have together received 96 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (2 papers) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Immunology (73 citations), Oncology (52 citations), Biotechnology (7 citations), Genetics (17 citations) and Hematology (5 citations). Mark Aleynick has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Joshua Brody, Judit Svensson‐Arvelund, Christopher R. Flowers, Aurélien Marabelle, Miriam Mérad, Linda Hammerich, Brian D. Brown, Ranjan Upadhyay, Michael Yellin and Christine Moussion. Their work appears in journals such as Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Nature Communications and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.